Accordingly, the pharma business (22 per cent of FY22 revenues) will be demerged into APL and the original speciality chemicals business will continue under AIL ...
The pharma segment’s EBIT margin shrunk 400 basis points in FY22 to 17 per cent (speciality business reported 17 per cent EBIT margin in FY22) owing to input material cost inflation. Accordingly, the pharma business (22 per cent of FY22 revenues) will be demerged into APL and the original speciality chemicals business will continue under AIL. The new shares of APL will be listed by mid-December, according to the company.
Aarti Industries Ltd.'s shares tumbled over 13 percent in intraday trade on Wednesday ahead of the record date for the demerger of its Pharma business.
The brokerage cited raw material sourcing challenges, downside risks to volume growth, and muted expansion in margins until the end of 2024. The management said it expected the revenue and profit of the pharma business to grow between 15-20 percent. IST4 Min(s) Read
As on record date, shareholders will receive one equity share of Aarti Pharmalabs for every four shares of Aarti Industries. The company had announced the ...
The stock is down 27 percent in the last six months and 32 percent year-to-date. According to global brokerage firm Morgan Stanley's September report, Aarti Industries is staring at raw material sourcing challenges and slow project ramp-up. As on record date, shareholders will receive one equity share of Aarti Pharmalabs for every four shares of Aarti Industries.
The company has plans to strengthen its manufacturing capability by adding over 50 new products in the pharma division with a Capex of Rs 350-500 crore in ...
The third-party service providers that generate these cookies, such as, social media platforms, have their own privacy policies, and may use their cookies to target advertisement to you on other websites, based on your visit to our sites. These cookies collect information about your activities on our sites as well as other sites to provide you targeted advertising. However, this will not prevent the sites from placing further cookies on your device unless and until you adjust your Internet browser setting as described above. If you subscribe to a newsletter or otherwise register with the Sites, these cookies may be correlated to you. Without these essential cookies we may not be able to provide certain services or features and our site will not perform as smoothly for you as we would like. We use persistent cookies to improve your experience of using the sites. However, if you select this setting you may be unable to access certain parts of the sites. Zeenews.com use cookies and other technologies to store information in your web browser or on your mobile phone, tablet, computer, or other devices (collectively "devices") that allow us to store and receive certain pieces of information whenever you use or interact with our zeenews.india.com applications and sites. These third-party service providers use persistent Cookies to help us improve user experience, manage our site content, and analyse how users navigate and utilize the sites. A cookie is a small text file that can be stored on and accessed from your device when you visit one of our sites, to the extent you agree. Likewise, if you share any content on this website through social networks (for example by clicking a Facebook “like” button or a “Tweet” button) you may be sent cookies from these websites. zeenews.india.com understands that your privacy is important to you and we are committed for being transparent about the technologies we use.